Novo Nordisk a S: Form 20-F for the period ended Dec 31, 2022
Filed with the SEC on Feb 1, 2023 and accepted by EDGAR at Feb 1, 2023, 07:53 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | DKK 176.95bn | ifrs-full:Revenue |
| Cost of revenue | 12 months2022-01-01 to 2022-12-31 | DKK 28.45bn | ifrs-full:CostOfSales |
| Gross profit | 12 months2022-01-01 to 2022-12-31 | DKK 148.51bn | ifrs-full:GrossProfit |
| Operating income | 12 months2022-01-01 to 2022-12-31 | DKK 74.81bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2022-01-01 to 2022-12-31 | DKK 13.54bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2022-01-01 to 2022-12-31 | DKK 55.52bn | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | DKK 24.44 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | DKK 24.51 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | DKK 78.89bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | DKK 12.15bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2022-12-31 | DKK 12.65bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2022-12-31 | DKK 108.19bn | ifrs-full:CurrentAssets |
| Total assets | At period end2022-12-31 | DKK 241.26bn | ifrs-full:Assets |
| Current liabilities | At period end2022-12-31 | DKK 120.94bn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2022-12-31 | DKK 157.77bn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2022-12-31 | DKK 83.49bn | ifrs-full:Equity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-001868. Last ingested by Listed: Nov 3, 2026, 11:50 ET. Listed shows no prices and gives no investment advice.